ANI Pharmaceuticals ANIP Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by ANI Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseCurrent.
The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about ANI Pharmaceuticals's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ANI Pharmaceuticals's prepaid & other current?
- ANI Pharmaceuticals (ANIP) reported prepaid & other current of $22.09M in Q1 2026.
- How has ANI Pharmaceuticals's prepaid & other current changed year-over-year?
- ANI Pharmaceuticals's prepaid & other current decreased by 5.3% year-over-year, from $23.33M to $22.09M.
- What is the long-term trend for ANI Pharmaceuticals's prepaid & other current?
- Over 5 years (2020 to 2025), ANI Pharmaceuticals's prepaid & other current has grown at a 42.3% compound annual growth rate (CAGR), from $5.86M to $34.22M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.